title: Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease.
abstract: The relationship between airway inflammation and structural changes of airway remodeling, and their relative effects on airway function, are poorly understood. Remodeling is thought to result from chronic repetitive injury to the airway wall caused by airway inflammation; however, the mechanisms regulating remodeling changes have not been clearly defined. We examined the sequence of events in remodeling using three commonly used mouse models of allergic airways disease in which mice are exposed to nebulized ovalbumin for four consecutive days (acute), seven consecutive days (subacute), or three times a week for 6 wk (chronic). Surprisingly, we found that a very short period of exposure to ovalbumin was sufficient to elicit early changes of remodeling. Goblet cell hyperplasia and epithelial thickening were evident after just 4 d. In chronically challenged mice, these changes persisted and, in addition, subepithelial collagen deposition was significantly increased. This collagen deposition was associated with a failure to upregulate matrix metalloproteinase (MMP)-2, in conjunction with increased transforming growth factor-beta and MMP-9 expression. The relationship between inflammation, remodeling changes, and airway hyperresponsiveness (AHR) were examined. The acute and subacute models exhibited marked airway inflammation, whereas the chronic model had very modest inflammation. Conversely, airway fibrosis was only evident in the chronic model. AHR was present in all three models; however, it was significantly higher in the chronic model compared with the acute (P<0.05) and subacute (P<0.05) models. These data demonstrate that both airway inflammation and airway fibrosis may contribute to AHR, with airway fibrosis leading to the greatest increases in AHR.
authors.affiliation: Department of Allergy and Immunology, Royal Children's Hospital, and Howard Florey Institute of Experimental Physiology and Medicine, the University of Melbourne, Parkville, Victoria 3052, Australia.
authors.forename: Natasha R
authors.initials: NR
authors.lastname: Locke
authors.forename: Simon G
authors.initials: SG
authors.lastname: Royce
authors.forename: Jacquetta S
authors.initials: JS
authors.lastname: Wainewright
authors.forename: Chrishan S
authors.initials: CS
authors.lastname: Samuel
authors.forename: Mimi L
authors.initials: ML
authors.lastname: Tang
mesh_terms: D000208:Acute Disease; D000818:Animals; D016535:Bronchial Hyperreactivity / Q000139:chemically induced / Q000503:physiopathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002452:Cell Count; D002908:Chronic Disease; D004195:Disease Models, Animal; D007073:Immunoglobulin E / Q000097:blood; D007150:Immunohistochemistry; D007249:Inflammation; D008168:Lung / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin; D012130:Respiratory Hypersensitivity / Q000139:chemically induced / Q000503:physiopathology*; D053773:Transforming Growth Factor beta1 / Q000378:metabolism
chemical_list: D053773:Transforming Growth Factor beta1; D007073:Immunoglobulin E; D010047:Ovalbumin; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9